Kymab

Kymab

Continually improving the best antibody technologies

Human health & social work | United Kingdom of Great Britain and Northern Irela | Access to Information |

 Profile Provided By: Company Website

Overview

Kymab is discovering and developing fully human monoclonal antibody therapeutics using our pioneering Kymouse platform. Kymab is building a rich pipeline of assets in four therapeutic spaces immuno oncology inflammation haematology and infectious diseases.

Industry

Legal Structure

Operating Status

Employees

Human health & social work Limited Liability Company Operating 51 - 200 employees

Funding and Financing Rounds


Team


Impact

Social Objectives:

Environmental Objectives:

Operational Impact:


Impact Reports & Metrics


Offices

Headquarters

Meditrina Babraham Research
Campus Cambridge, CB22 3AT
United Kingdom of Great Britain and Northern Irela



Explore

Revision History

Last Update: Oct 07, 2017 8:48 p.m.

Quick Search



  • Global  
  • Africa  
  • Americas  
  • Asia  
  • Europe  
  • Oceania  


News & Links

Incoming

Tags

COPYRIGHT 2017 IMPACTSPACE. ALL RIGHTS RESERVED.